Looking Ahead at the Neurology Clinical Trial Space in the P

Looking Ahead at the Neurology Clinical Trial Space in the Post-COVID-19 Landscape, Upcoming Webinar Hosted by Xtalks


Looking Ahead at the Neurology Clinical Trial Space in the Post-COVID-19 Landscape, Upcoming Webinar Hosted by Xtalks
Share Article
In this free webinar, the featured speakers will discuss what neurological clinical trials will look like beyond COVID-19 protocols. It will focus on the recruitment landscape, decentralized landscape and therapeutic landscape.
Today’s neurological studies now need to take into account the patient burden, clinical site safety, and even pre-existing neurological conditions caused by the COVID-19 infection to reach successful trial completion.
TORONTO (PRWEB)
April 07, 2021
For pharmaceutical and medical device companies, navigating the neurology clinical trial space in the wake of COVID-19 requires balancing between critical study milestones and patient safety. With the post-pandemic landscape becoming the new clinical trial status quo, neurology research must now execute the best strategies available to adapt and pivot quickly across all central nervous system (CNS) studies.

Related Keywords

United Kingdom , Jimmy El Hokayem , Program Development , Regenerative Medicine Centers Of Excellence , Honeycomb Worldwide Inc , Harvard Medical School , Regenerative Medicine Centers , Associate Director , Ole Isacson , Looking Ahead , Neurology Clinical Trial Space , Life Science , ஒன்றுபட்டது கிஂக்டம் , ப்ரோக்ர்யாம் வளர்ச்சி , மீளுருவாக்கம் மருந்து மையங்கள் ஆஃப் சிறப்பானது , தேன்கூடு உலகளவில் இன்க் , ஹார்வர்ட் மருத்துவ பள்ளி , மீளுருவாக்கம் மருந்து மையங்கள் , இணை இயக்குனர் , நரம்பியல் மருத்துவ சோதனை இடம் , வாழ்க்கை அறிவியல் ,

© 2025 Vimarsana